Top of page
Global Site Navigation

Treating Alcohol and Drugs in Primary Care (TADPole)

Local Section Navigation
You are here: Main Content

Novel Psychoactive Substances

Dr Stephen Bright

Dr Bright oversees the development and delivery of curriculum pertaining to the use of Alcohol and Other Drugs (AOD) in the context of society.


Stephen has worked as a psychologist within the Mental Health & AOD field for the past 15 years. He is currently Senior Lecturer of Addiction at Edith Cowan University. Stephen is a strong advocate of harm reduction and an evidence-based approach to AOD legislation. He is also interested in the role of certain substances (entheogens) to facilitate spiritual experiences, and their role in psychotherapy.

His PhD related to the public perceptions and media portrayal of AOD use and the implications of this for drug-related harm, including the rapid emergence of new psychoactive substances. This has led to the development of a project that aims to make the Australian media more accountable when reporting on AOD issues:

Stephen is a leading Australian voice on the role of drug policy on emerging drug trends such as synthetic cannabis and darkweb marketplaces.

For more information about Stephen visit his ECU staff profile page.

About this resource

There has been the rapid emergence of a range of new and novel psychoactive substances. Initially, many of these were Synthetic Cannabinoid Receptor Agonists (SCRAs) that were being used to produce synthetic cannabis products such as ‘Kronic’. As Stephen discusses in this resource, bans on individual chemicals led to new SCRAs that appear to be more toxic than the original SCRAs.

WA Primary Health AlliancePrimary Health Network: Perth North, Perth South, Country WA

Skip to top of page